These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23155228)
1. Gene expression and protein array studies of folliculin-regulated pathways. Reiman A; Lu X; Seabra L; Boora U; Nahorski MS; Wei W; Maher ER Anticancer Res; 2012 Nov; 32(11):4663-70. PubMed ID: 23155228 [TBL] [Abstract][Full Text] [Related]
2. Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin. Tee AR; Pause A Fam Cancer; 2013 Sep; 12(3):367-72. PubMed ID: 23096221 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (FLCN). Lu X; Boora U; Seabra L; Rabai EM; Fenton J; Reiman A; Nagy Z; Maher ER Oncogene; 2014 Feb; 33(8):956-65. PubMed ID: 23416984 [TBL] [Abstract][Full Text] [Related]
4. Folliculin deficient renal cancer cells show higher radiosensitivity through autophagic cell death. Zhang Q; Si S; Schoen S; Jin XB; Chen J; Wu G J Urol; 2014 Jun; 191(6):1880-8. PubMed ID: 24434776 [TBL] [Abstract][Full Text] [Related]
5. Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility. Preston RS; Philp A; Claessens T; Gijezen L; Dydensborg AB; Dunlop EA; Harper KT; Brinkhuizen T; Menko FH; Davies DM; Land SC; Pause A; Baar K; van Steensel MA; Tee AR Oncogene; 2011 Mar; 30(10):1159-73. PubMed ID: 21057536 [TBL] [Abstract][Full Text] [Related]
6. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic. Enomoto Y; Namba Y; Hoshika Y; Komemushi Y; Mitani K; Kume H; Kobayashi E; Miyama Y; Homma Y; Ushiku T; Seyama K Eur J Med Genet; 2020 Apr; 63(4):103820. PubMed ID: 31778855 [TBL] [Abstract][Full Text] [Related]
7. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development. Baba M; Keller JR; Sun HW; Resch W; Kuchen S; Suh HC; Hasumi H; Hasumi Y; Kieffer-Kwon KR; Gonzalez CG; Hughes RM; Klein ME; Oh HF; Bible P; Southon E; Tessarollo L; Schmidt LS; Linehan WM; Casellas R Blood; 2012 Aug; 120(6):1254-61. PubMed ID: 22709692 [TBL] [Abstract][Full Text] [Related]
8. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome. Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584 [TBL] [Abstract][Full Text] [Related]
9. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome. Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100 [TBL] [Abstract][Full Text] [Related]
10. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin. Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504 [TBL] [Abstract][Full Text] [Related]
11. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome. Nishii T; Tanabe M; Tanaka R; Matsuzawa T; Okudela K; Nozawa A; Nakatani Y; Furuya M Pathol Int; 2013 Jan; 63(1):45-55. PubMed ID: 23356225 [TBL] [Abstract][Full Text] [Related]
12. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation. Clausen L; Stein A; Grønbæk-Thygesen M; Nygaard L; Søltoft CL; Nielsen SV; Lisby M; Ravid T; Lindorff-Larsen K; Hartmann-Petersen R PLoS Genet; 2020 Nov; 16(11):e1009187. PubMed ID: 33137092 [TBL] [Abstract][Full Text] [Related]
13. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas. Näf E; Laubscher D; Hopfer H; Streit M; Matyas G Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubé syndrome. Chu L; Luo Y; Chen H; Miao Q; Wang L; Moats R; Wang T; Kennedy JC; Henske EP; Shi W Thorax; 2020 Jun; 75(6):486-493. PubMed ID: 32238524 [TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling. Hong SB; Oh H; Valera VA; Stull J; Ngo DT; Baba M; Merino MJ; Linehan WM; Schmidt LS Mol Cancer; 2010 Jun; 9():160. PubMed ID: 20573232 [TBL] [Abstract][Full Text] [Related]
16. Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK. Goncharova EA; Goncharov DA; James ML; Atochina-Vasserman EN; Stepanova V; Hong SB; Li H; Gonzales L; Baba M; Linehan WM; Gow AJ; Margulies S; Guttentag S; Schmidt LS; Krymskaya VP Cell Rep; 2014 Apr; 7(2):412-423. PubMed ID: 24726356 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting the loss of the birt-hogg-dube suppressor gene. Lu X; Wei W; Fenton J; Nahorski MS; Rabai E; Reiman A; Seabra L; Nagy Z; Latif F; Maher ER Mol Cancer Ther; 2011 Jan; 10(1):80-9. PubMed ID: 21220493 [TBL] [Abstract][Full Text] [Related]
18. Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein. Laviolette LA; Mermoud J; Calvo IA; Olson N; Boukhali M; Steinlein OK; Roider E; Sattler EC; Huang D; Teh BT; Motamedi M; Haas W; Iliopoulos O Nat Commun; 2017 Jun; 8():15866. PubMed ID: 28656962 [TBL] [Abstract][Full Text] [Related]
19. Birt-Hogg-Dube syndrome is a novel ciliopathy. Luijten MN; Basten SG; Claessens T; Vernooij M; Scott CL; Janssen R; Easton JA; Kamps MA; Vreeburg M; Broers JL; van Geel M; Menko FH; Harbottle RP; Nookala RK; Tee AR; Land SC; Giles RH; Coull BJ; van Steensel MA Hum Mol Genet; 2013 Nov; 22(21):4383-97. PubMed ID: 23784378 [TBL] [Abstract][Full Text] [Related]
20. FLCN-regulated miRNAs suppressed reparative response in cells and pulmonary lesions of Birt-Hogg-Dubé syndrome. Min H; Ma D; Zou W; Wu Y; Ding Y; Zhu C; Lin A; Song S; Liang Q; Chen B; Zhang B; Wan Y; Ye M; Pan Y; Wen Y; Yi L; Gao Q Thorax; 2020 Jun; 75(6):476-485. PubMed ID: 32184379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]